Isodiol International Inc. (CSE:ISOL) (OTC:ISOLF) (FSE:LB6A.F)(the “Company” or “Isodiol”), a global Bioactive Phytoceutical innovator specializing in the development of pharmaceutical and wellness products, announces that Jazmine Fenlator, Kiley McKinnon, Kimani Griffin, Faye Gulini, and Julia Marino have been appointed as brand ambassadors for ISO-Sport to demonstrate and discuss the health benefits of cannabidiol (CBD) for professional athletes.

In January 2018, the World Anti-Doping Agency (WADA) took the position of excepting “Cannabidiol” from the list of cannabinoids contained in their List of Prohibited Substances and Methods (Prohibited List).  Publication of the Prohibited List is mandated by the World Anti-Doping Code, to which there are over 660 nation and athletic governing body signatories, including:


  • US Anti-Doping Agency (USADA)
  • National Anti-Doping Organization of Paraguay
  • Jamaica Anti-Doping Commission (JADCO)
  • Bobsleigh & Skeleton (IBSF) – International Bobsleigh & Skeleton Federation
  • Ski (FIS) – International Ski Federation

Marcos Agramont, CEO of Isodiol, stated “Isodiol proudly supports the forward-thinking of these signatory bodies and their efforts to improve the lives of our athlete brand ambassadors at this year’s Winter Olympics and beyond.  As long as we have the support of the athletic community, we will continue to release the most innovative and trusted phytoceutical products available to peak performance athletes in the industry.”

Isodiol’s ISO-Sport athletes can be seen competing in the women’s bobsleigh (Jazmine Fenlator – @JazmineFenlator), women’s aerial freestyle skiing (Kiley McKinnon – @kiley.mckinnon), men’s long track speedskating (Kimani Griffin – @kgriff90), women’s snowboarding (Faye Gulini – @Faye Gulini), and women’s slopestyle and big air snowboarding (Julia Marino – @_juliamarino).  Follow them on Twitter and Instagram as they earn their way to the podium.

“We hope that everyone at home will join us at Isodiol and ISO-Sport in cheering on Jazmine, Kiley, Kimani, Faye, and Julia over the coming weeks as they give their all for nation, sport, and themselves in the winter games in PyeongChang,” said Mr. Agramont.

For more information on Isodiol, please visit www.isodiol.com

About Isodiol International Inc.

Isodiol International Inc. is the market leader in pharmaceutical grade phytochemical compounds and the industry leader in the manufacturing and development of phytoceutical consumer products.

Isodiol is the pioneer of many firsts for the cannabis industry including commercialization of 99%+ pure, bioactive pharmaceutical grade cannabinoids, micro-encapsulations, and nanotechnology for the highest quality consumable and topical skin care products.

Isodiol’s growth strategy includes the development of over-the-counter and pharmaceutical drugs, expanding its phytoceutical portfolio and will aggressively continue international expansion into Latin America, Asia and Europe.

ON BEHALF OF THE BOARD
Marcos Agramont, CEO & Director

INVESTOR RELATIONS:
Ir@isodiol.com
www.isodiol.com

Forward-Looking Information: This news release contains “forward-looking information” within the meaning of applicable securities laws relating to statements regarding the Company’s business, products and future the Company’s business, its product offerings and plans for sales and marketing. Although the Company believes that the expectations reflected in the forward-looking information are reasonable, there can be no assurance that such expectations will prove to be correct. Readers are cautioned to not place undue reliance on forward-looking information. Such forward looking statements are subject to risks and uncertainties that may cause actual results, performance and developments to differ materially from those contemplated by these statements depending on, among other things, the risks that the Company’s products and plan will vary from those stated in this news release and the Company may not be able to carry out its business plans as expected. Except as required by law, the Company expressly disclaims any obligation, and does not intend, to update any forward-looking statements or forward-looking information in this news release. Although the Company believes that the expectations reflected in the forward-looking information are reasonable, there can be no assurance that such expectations will prove to be correct and makes no reference to profitability based on sales reported. The statements in this news release are made as of the date of this release.

The CSE has not reviewed, approved or disapproved the content of this press release.

Click here to connect with Isodiol International LLC (CSE:ISOL, OTC:LAGBF, FSE:LBGA.F) for an Investor Presentation.

Source: globenewswire.com

Strong Innovation Pipeline Continues to Drive Market Share Growth
Broken Coast’s First Foray into Cannabis 2.0
Solei Introduces First Limited Release Vape on the Market
Solei, RIFF, Good Supply and B!NGO Expand Product Offerings

Aphria Inc. (” Aphria ” or the ” Company “) ( TSX: APHA and NASDAQ: APHA ), a leading global cannabis company inspiring and empowering the worldwide community to live their very best life, today announced the expansion of its 510 Vape offering across its award-winning adult-use brand portfolio.

Keep reading... Show less

Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of Aurora Cannabis Inc. (NYSE: ACB) between February 13, 2020 and September 4, 2020, inclusive (the “Class Period”). If you wish to serve as lead plaintiff, you must move the Court before the December 1 2020 DEADLINE . A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

To join the class action, go to http://zhanginvestorlaw.com/join-action-form/?slug=aurora-cannabis-inc&id=2437 or call Sophie Zhang, Esq. toll-free at 800-991-3756 or email info@zhanginvestorlaw.com for information on the class action.

Keep reading... Show less

Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) (“Nextleaf Solutions“, “OILS”, or the “Company”), Canada’s most innovative cannabis extractor, is pleased to provide the following commercial and intellectual property update:

Cannabis Extraction Agreement with White Label Producer

Keep reading... Show less

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES

Khiron Life Sciences Corp. (“ Khiron ” or, the “ Company ”) (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe, is pleased to announce that it has closed today its previously announced “bought deal” short form prospectus offering of units (“ Unit s ”), including the exercise in full of the over-allotment option (the “ Offering ”).

Keep reading... Show less

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein, Executive Chairman, is scheduled to speak on a panel at the Cowen 2020 Boston Cannabis Conference on Wednesday, December 2, 2020 at 9:20 a.m. EST.

For more information regarding the Cowen 2020 Boston Cannabis Conference please visit: https://www.cowen.com/conferences-and-events/3rd-annual-boston-cannabis-conference/

Keep reading... Show less